However, brain natriuretic peptides appear to be potential early indicators of late cardiotoxicity during cancer survivorship as they have been associated with increased LV dimensions and echocardiographic features of systolic and diastolic dysfunction [39–41, 56, 57, 64, 65]. This evidence concerns the gene NPPB and cancer.